EP2439273
Manna einstofna mótefni gegn stýrðum dauða 1 (PD-1) og aðferðir til að meðhöndla krabbamein með því að nota mótefni gegn PD-1 ein og sér eða ásamt annarri ónæmismeðferð
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
2.5.2006EP published:
27.2.2019EP application number:
11178191.0
EP translation filed:
23.5.2019Grant published:
15.7.2019EPO information:
European Patent Register
Max expiry date:
1.5.2026Expiry date:
1.5.2021
Title:
Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
Timeline
Today
2.5.2006EP application
27.2.2019EP Publication
23.5.2019Translation submitted
15.7.2019Registration published
1.5.2021Expires
Owner
Name:
ONO PHARMACEUTICAL CO., LTD.Address:
1-5, Doshomachi 2-chome Chuo-ku, 541-8526, Osaka-shi, Osaka, JP
Name:
E. R. Squibb & Sons, L.L.C.Address:
Route 206 & Province Line Road, 08540, Princeton, NJ, US
Inventor
Name:
Srinivasan, MohanAddress:
Redwood City,CA, US
Name:
Wang, ChangyuAddress:
Redwood City,CA, US
Name:
Selby, Mark, J.Address:
Redwood City,CA, US
Name:
Chen, BingAddress:
Redwood City,CA, US
Name:
Cardarelli, Josephine, M.Address:
Redwood City,CA, US
Name:
Korman, Alan, J.Address:
Redwood City,CA, US
Name:
Huang, HaichunAddress:
Redwood City,CA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
679466 PDate:
9.5.2005Country:
US
Number:
738434 PDate:
21.11.2005Country:
US
Number:
748919 PDate:
8.12.2005Country:
US
Classification
Categories:
C12N 15/09, C07K 16/28, C12N 5/00, C12P 21/08, C12Q 1/02
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 5.4.2019
Expires: 1.5.2020
Payer: Árnason Faktor
Number: 15
Paid: 7.4.2020
Expires: 1.5.2021
Payer: Árnason Faktor ehf.